Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for clinical trial data
How plausible may be a conference on IP (and regulatory) exclusivity? Sufficiently How plausible may be a conference on IP (and regulatory) exclusivity? Sufficiently Reviewed by Gabriele Girardello on Monday, November 14, 2022 Rating: 5
Clinical trial data, motivated intruders and freedom of information Clinical trial data, motivated intruders and freedom of information Reviewed by Annsley Merelle Ward on Tuesday, September 06, 2016 Rating: 5
Patents and publication of dose regimes: can you help? Patents and publication of dose regimes: can you help? Reviewed by Jeremy on Thursday, August 23, 2012 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.